Thrombophilia in Pregnancy

Annals of the Academy of Medicine Singapore

Volumn 31, Issue 3, 2002, Pages 328-334

  Tan, Jackie Y L ^a  

^a TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

Intrauterine growth restriction; Placental abruption; Pre eclampsia; Recurrent miscarriage; Thromboprophylaxis; Venous thromboembolism

Indexed keywords

BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN; FIBRINOLYTIC AGENT; PROTHROMBIN;

ANTIPHOSPHOLIPID SYNDROME; ASIAN; CAUCASIAN; CLASSIFICATION; FEMALE; GENETICS; HIGH RISK PREGNANCY; HUMAN; HYPERHOMOCYSTEINEMIA; INCIDENCE; MASS SCREENING; MATERNAL MORTALITY; METHODOLOGY; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PRIMARY PREVENTION; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; REVIEW; RISK FACTOR; THROMBOPHILIA;

ANTIPHOSPHOLIPID SYNDROME; ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; FACTOR V; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; HYPERHOMOCYSTEINEMIA; INCIDENCE; MASS SCREENING; MATERNAL MORTALITY; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY OUTCOME; PREGNANCY, HIGH-RISK; PRIMARY PREVENTION; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; PROTHROMBIN; RISK FACTORS; THROMBOPHILIA;

EID: 0036581655     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Kierkegaard A. Incidence and diagnosis of deep vein thrombosis associated with pregnancy. Acta Obstet Gynecol Scand 1983; 62: 239-43.
2. McColl M D, Ramsay J E, Tait R C, Walker I D, McCall F, Conkie J A, et al. Risk factors for pregnancy associated venous thromboembolism. Thromb Haemost 1997; 78:1183-8.
3. Lindqvist P, Dahlback B, Marsal K. Thrombotic risk during pregnancy: a population study. Obstet Gynecol 1999; 595-9.
4. Chan L Y, Tam W H, Lau T K. Venous thromboembolism in pregnant Chinese women. Obstet Gynecol 2001; 98:471-5.
5. Lau G. Are maternal deaths on the ascent in Singapore? A review of maternal mortality as reflected in coronial casework from 1990 to 1999. Ann Acad Med Singapore 2002; 31:261-75.
6. Greer I A. Thrombosis in pregnancy: maternal and fetal issues. Lancet 1999; 353:1258-65.
7. Polak J F, Wilkinson D L. Ultrasonographic diagnosis of symptomatic deep vein thrombosis in pregnancy. Am J Obstet Gynecol 1991; 165:625-9.
8. Lao T T, Yuen P M, Yin J A. Protein C and protein S levels in Chinese women during pregnancy, delivery and the puerperium. Br J Obstet Gynaecol 1989; 96:167-70.
9. Macklon N S, Greer I A, Bowman A W. An ultrasound study of gestational and postural changes in the deep venous system of the leg in pregnancy. Br J Obstet Gynaecol 1997; 104:191-7.
10. Heijboer H, Brandjes D P, Buller H R, Sturk A, Cate J W. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep venous thrombosis. N Engl J Med 1990; 323:1512-6.
11. Shen M C, Lin J S, Tsay W. Protein C and protein S are the most important risk factors associated with thrombosis in Chinese thrombophilic patients in Taiwan. Thromb Res 2000; 99:447-52.
12. Ho C H, Chau W K, Hsu H C, Gau J P, Yu T J. Causes of venous thrombosis in 50 Chinese patients. Am J Hematol 2000; 63:74-8.
13. Bai C, Pan J, Fan L. A study on the deficiency of antocoagulant protein in Chinese patients with deep vein thrombosis. Zhonghua Nei Ke Za Zhi 2000; 39:746-8.
14. Lim L C, Tan H H, Lee L H, Tien S L, Abdul Ghafar A. Activated protein C resistance: a study among 60 thrombotic patients in the Singapore population. Ann Acad Med Singapore 1999; 28:252-5.
15. Finazzi G, Caccia R, Barbui T. Different prevalence of thromboembolism in the subtypes of congenital antithrombin III deficiency: review of 404 cases [letter]. Thromb Haemost 1987; 58:1094.
16. Tait R C, Walker I D, Perry D J, Islam S I, Daly M E, McCall F, et al. Prevalence of antithrombin deficiency in the healthy population. Br J Haematol 1994; 87:106-12.
17. Walker I D. Thrombophilia in pregnancy. J Clin Pathol 2000; 53: 573-80.
18. Bertina R M, Koeleman B P, Koster T, Rosendaal F R, Dirven R J, deRonde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369:64-7.
19. Rees D C, Cox M, Clegg J B. World distribution of factor V Leiden. Lancet 1995; 346:1133-4.
20. Rosendaal F R, Koster T, Vabdenbrouke J P, Reitsma P H. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 1995; 85:1504-8.
21. Poort S R, Rosendaal F R, Reitsma P H, Bertina R M. A common genetic variant in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in thrombosis. Blood 1996; 88:3698-703.
22. Rosendaal F R, Doggen C J, Zivelin A, Arruda V R, Aiach M. Siscovick D S, et al. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 1998; 79:706-8.
23. Oshiro B T, Silver R M, Scott J R, Yu H, Branch D W. Antiphospholipid antibodies and fetal death. Obstet Gynecol 1996; 87:489-93.
24. Harris E N, Chan J K, Asherson R A, Aber V R, Gharavi A E, Hughes G R, et al. Thrombosis, recurrent fetal loss and thrombocytopenia. Predictive value of the anticardiolipin antibody test. Arch Intern Med 1986; 146:2153-6.
25. Reece E A, Garofalo J, Zheng X Z, Assimakopoulos E. Pregnancy outcome-influence of antiphospholipid antibody titer, prior pregnancy loss and treatment. J Reprod Med 1997; 42:49-55.
26. Lynch A, Marlar R, Murphy J, Davila G, Santos M, Rutledge J, et al. Antiphospholipid antibodies in predicting adverse pregnancy outcome. A prospective study. Ann Intern Med 1994; 120:470-5.
27. Porter T F, Silver R M, Branch D W. Pregnancy loss and antiphospholipid antibodies. In: Khamashta M A, editor. Hughes Syndrome: Antiphospholipid Syndrome. London: Springer-Verlag, 2000:179-94.
28. Wilson W A, Gharavi A E, Koike T, Lockshin M D, Branch D W, Piette J C, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Report of an International Workshop. Arthritis Rheum 1999; 42:1309-11.
29. Parke A L. Placental pathology in antiphospholipid antibody syndrome. In: Khamashta M A, editor. Hughes Syndrome: Antiphospholipid Syndrome. London: Springer-Verlag, 2000:281-9.
30. Rote N S. Antiphospholipid antibodies and placental development. Fetal Mat Med Rev 1997; 9:181-97.
31. Kutteh W H. Antiphospholipid antibody-associated recurrent pregnancy loss - treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996; 174:1584-9.
32. Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997; 314:253-7.
33. Mudd S H, Levy H L, Skovby F. Disorders of transulfuration. In: Scriver C R, Beaudet A L, Sly W S, Valle D, Stanbury J B, Wyngarden J B, et al, editors. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill, 1995:1279-327.
34. Cuba S C, Fonseca V, Fink L M. Hypcrhomocysteinaemia and thrombosis. Semin Thromb Hemost 1999; 25:291-309.
35. Homocysteine Lowering Trialists' Collaboration. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. BMJ 1998; 316:894-8.
36. Koster T, Blann A D, Briet E, Vandenbroucke J P, Rosendaal F R. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep vein thrombosis. Lancet 1995; 345:152-5.
37. Meijers JCM, Tekelenburg WLH, Bouma B N, Bertina R M, Rosendaal F R. High levels of coagulation factor XI as a risk factor for venous thrombosis. N Engl J Med 2000; 342:696-701.
38. Gerhardt A, Scharf R E, Beckmann M W, Struve S, Bender H G, Pillny M, et al. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med 2000; 342:374-80.
39. Royal College of Obstetricians and Gynaecologists. Report of the RCOG Working Party on Prophylaxis against Thromboembolism in Gynaecology and Obstetrics. London: Chameleon Press Ltd, 1995.
40. Brill-Edwards P, Ginsberg J S, Gent M, Hirsh J, Burrows R, Kearon C. et al. Safety of withholding heparin in pregnant women with a history of venous thromboembolism. N Engl J Med 2000; 343:1439-44.
41. Thromboembolic Risk Factors (THRIFT) Consensus Group. Risk of and prophylaxis for venous thromboembolism in hospital patients. BMJ 1992; 305:567-74.
42. Kupfermine M J, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A. et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999; 340:9-13.
43. Eldor A, Kupfermine M J, Steinman N. Low molecular weight heparin during pregnancy for women with previous obstetric complications and thrombophilia. Thromb Haemost 1999; 58(Suppl):174.